Clinical Trial

The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD

Name: The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD — clinical trial record (NCT05469607)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety of vagal nerve neuromodulation in a cohort of patients operated on for Crohn's disease, in a prospective, single centre, cohort study.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2022-07-18.

Trial Details

NCT Number	NCT05469607
Lead Sponsor	Austin Health Collaborators: The Florey Institute of Neuroscience and Mental Health, University of Melbourne, The Bionics Institute of Australia, University of Queensland Diamantina Institute
Conditions	Crohn Disease
Enrollment	13 participants
Start Date	2022-07-08
Primary Completion	2026-12 (estimated)
Study Completion	2028-07 (estimated)
Updated on ClinicalTrials.gov	2023-02-08